Dyne therapeutics market cap
WebMarket Cap 781.90M. Shares Outstanding 52.13M. EPS (TTM) -3.2357. P/E (TTM) -Fwd Dividend (% Yield) -Ex-Dividend Date - ... Dyne Therapeutics Inc. is a muscle disease company ... WebMar 23, 2024 · DYN Complete Dyne Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. ... Market Cap $646.76M; Shares Outstanding …
Dyne therapeutics market cap
Did you know?
WebDyne Therapeutics Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... Market Cap: capitalization or market value of a stock is simply the market value of all outstanding shares. It is computed by multiplying the market price by the number of outstanding shares. WebFind real-time DYN - Dyne Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. ... Market cap: $528.5M: Data as of 3:59pm ET, 04/10/2024. Growth & Valuation.
WebMar 17, 2024 · Dyne Therapeutics stock opened at $12.85 on Friday. Dyne Therapeutics has a 52 week low of $4.30 and a 52 week high of $15.63. The firm has a market cap of … WebApr 11, 2024 · The firm has a market capitalization of $496.90 million, a P/E ratio of -2.72 and a beta of 0.24. Dyne Therapeutics has a 12 month low of $4.30 and a 12 month high of $15.63.
WebDyne Therapeutics Inc Working Capital Per Revenue on the trailing twelve month basis from the forth quarter 2024 to forth quarter 2024, Trends and Ranking, Fundamental Ratios - CSIMarket Company Name, Ticker, Suppliers, else.. WebMar 29, 2024 · Get a real-time Dyne Therapeutics, Inc. (DYN) stock price quote with breaking news, financials, statistics, charts and more. ... Market Cap: 628.17M: Revenue (ttm) n/a: Net Income (ttm)-168.10M: Shares Out 56.34M: EPS (ttm)-3.23: PE Ratio ... Chardan Initiates Coverage On These 'Intriguing Small-Cap Stories" Chardan Research …
WebDyne Therapeutics Inc market cap is $489.02M. What is the 52-week high for Dyne Therapeutics Inc? 52 week high is the highest price of a stock in the past 52 weeks, or …
WebInformation on stock, financials, earnings, subsidiaries, investors, and executives for Dyne Therapeutics. Use the PitchBook Platform to explore the full profile. Information on stock, financials, earnings, subsidiaries, investors, and executives for Dyne Therapeutics. ... Market Cap Shares Average Volume EPS; $9.38: $9.11: $4.30 - $15.63 ... shy text generatorWebFounded. 2024. Dyne Therapeutics, Inc. engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystroph. shy teenager singing tina turnerWebDyne Therapeutics to Present at Upcoming Investor Conferences. WALTHAM, Mass., March 07, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that … the peace sign with fingersWebGet the latest Dyne Therapeutics Inc (DYN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment … shythdf3Web19 hours ago · Find the latest Price To Free Cash Flow for Dyne Therapeutics (DYN) ... Large-Cap Trader; ... 03/23/23-11:00AM EST Market News Video Dyne Therapeutics Receives FDA Orphan Drug and Rare Pediatric ... shy thai songWebDyne Therapeutics (DYN) has a Smart Score of 7 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. ... shy thanksWebReal time Dyne Therapeutics (DYN) stock price quote, stock graph, news & analysis. the peace that jesus gives